TREM1 and pancreatitis: TREM1-mediated amplification of proinflammatory immune responses worsens outcomes in models of infection such as sepsis (20) and non-infectious models, including rheumatoid arthritis (21), pancreatitis (22), atherosclerosis (23), and chronic obstructive pulmonary disease (24).